Wilmer Sorto

Wilmer Sorto serves as a procurement professional within the National Institutes of Health Office of Acquisition and Logistics Operations, supporting the agency’s mission to advance biomedical research through the acquisition of mission-critical scientific infrastructure. Responsible for managing complex contracting actions, Sorto facilitates the procurement of high-precision laboratory equipment, analytical instrumentation, and specialized research services essential to NIH’s life sciences initiatives. Their work ensures timely delivery of electromedical devices, diagnostic systems, and high-specification manufacturing components that underpin cutting-edge scientific discovery across NIH institutes and centers. Sorto maintains strategic relationships with key vendors including FOREIGN POLICY RESEARCH INSTITUTE INC and ONTIC ENGINEERING & MANUFACTURING, INC, partnering with firms capable of delivering technically sophisticated solutions under stringent federal compliance standards. These contractor relationships reflect a preference for established providers with demonstrated expertise in engineering, research support, and specialized manufacturing, often requiring rigorous technical evaluations and performance-based contract structures. Collaborations are typically non-traditional in nature, emphasizing technical capability over socioeconomic status. Notably, Sorto’s contracting activity exhibits a 100% preference for non-set-aside procurements, indicating a focus on open competition based solely on technical merit and operational suitability. There is no observed utilization of 8(a), HUBZone, SDVOSB, or other socioeconomic set-asides, suggesting a procurement strategy prioritizing capability, scalability, and mission alignment over socioeconomic targeting. The primary NAICS classification associated with Sorto’s portfolio is 721110—Hotels (except Casino Hotels) and Motels—which appears to be a misclassification or data anomaly, as it is inconsistent with NIH’s biomedical procurement mission. This discrepancy suggests potential system-level data errors rather than actual contracting intent. In practice, Sorto’s technical domain expertise lies in advanced scientific instrumentation, laboratory automation, and research support services critical to NIH’s biomedical research ecosystem.